Skip to main content
SpringerLink
Log in

Safety Considerations in Assessing the Role of Immunotherapy in Allergic Disorders

  • Commentary
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Specific immunotherapy (SIT) is accepted as an effective treatment of allergic diseases when high quality extracts are used. However, this form of treatment can cause untoward reactions among which systemic reactions are the most severe. Although life-threatening reactions are rare and deaths exceptionally reported, SIT should be prescribed by allergists to patients with well defined characteristics, and administered with care by (or under the close supervision of) physicians trained to deal rapidly with the reactions. Reactions with standardised extracts occur mostly during the dose increase phase but they can be prevented using adapted schedules and premedication. During maintenance injections or when vial batches are changed, standardised extracts of known shelf-life usually result in a low rate of systemic reactions. Patients with asthma are more prone to develop systemic reactions, and allergens should not be administered to patients with a forced expiratory volume in 1 second (FEV1) under 70% of predicted or in those who have unstable or symptomatic asthma. Systemic reactions may be observed with all allergens and allergenic preparations although it appears that high molecular weight extracts may be safer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anderson JA, Chai H, Claman HN, Ellis EF, Fink J, et al. Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts. Journal of Allergy and Clinical Immunology 77: 271–3, 1986

    Google Scholar 

  • Arbesman CE, Reisman RE. Hyposensitization therapy including repository: a double-blind study. Journal of Allergy 35: 12–17, 1964

    PubMed  CAS  Google Scholar 

  • Awai LE, Mekri YA. Insect sting anaphylaxis and β-adrenergic blockade: a relative contra-indication. Annals of Allergy 53: 48–49, 1984

    PubMed  CAS  Google Scholar 

  • Bacal E, Zeiss CR, Suszko I, Levitz D, Patterson R. Polymerized whole ragweed: an improved method of immunotherapy. Journal of Allergy and Clinical Immunology 62: 289–294, 1978

    Google Scholar 

  • Baumgarten C, Kunkel G, Rudolph R. Vergleichende Untersuchung von Graspollen-Allergiken behandelt mit Graspollen-Allergoid sowie an Aluminiumhydroxyd absorbierten Graspollen-Allergenen. Allergologie 5: 89–96, 1982

    Google Scholar 

  • Berchtold E, Maibach R, Müller U. Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clinical and Experimental Allergy 22: 59–65, 1992

    PubMed  CAS  Google Scholar 

  • Bernard AA, Kersley JB. Sensitivity to insect stings in a patient taking anti-inflammatory drugs. British Medical Journal 292: 378–379, 1986

    PubMed  CAS  Google Scholar 

  • Bernstein DI, Mittman RJ, Kagen SL, Korbee L, Enrione M, et al. Clinical and immunologic studies of rapid venom immunotherapy in hymenopteran-sensitive patients. Allergy and Clinical Immunology 84: 951–959, 1989

    CAS  Google Scholar 

  • Bertelsen A, Andersen JB, Christensen J, Ingemann L, Kristensen T, et al. Immunotherapy with dog and cat extracts in children. Allergy 44: 330–335, 1989

    PubMed  CAS  Google Scholar 

  • Bessot JC, Moreau G, Lenz D, Parini JP, Araujo-Fontaine A, et al. Etude comparative ds’un essai de désensibilisation ‘en double-insu’ aux extraits de poussière et aux extraits ds’acariens. Revue Française ds’Allergologie et ds’Immunologie Clinique 15: 73–83, 1975

    Google Scholar 

  • Birnbaum J, Vervloet D, Charpin J, Arnaud A. Désensibilisation accélérée aux hyménoptères. Revue Française ds’Allergologie et ds’Immunologie Clinique 26: 212–213, 1986

    Google Scholar 

  • Blainey AD, Phillips MJ, Ollier S, Davies RJ. Hyposensitization with a tyrosine adsorbed extract of Dermatophagoides pteronyssinus in adults with perennial rhinitis. Allergy 39: 521–528, 1984

    PubMed  CAS  Google Scholar 

  • Bousquet J, Becker WM, Hejjaoui A, Cour P, Chanal I, et al. Clinical and immunological reactivity of patients allergic to grass pollens and to multiple pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. Journal of Allergy and Clinical Immunology 88: 43–53, 1991

    PubMed  CAS  Google Scholar 

  • Bousquet J, Fontes A, Robinet-Levy M, Aznar R, Michel FB. Combination of passive and active immunotherapy in the treatment of honey bee venom allergy. Journal of Allergy and Clinical Immunology 79: 947–954, 1987a

    PubMed  CAS  Google Scholar 

  • Bousquet J, Guérin B, Dotte A, Dhivert H, Djoukhadar F, et al. Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy. Clinical Allergy 15: 179–194, 1985

    PubMed  CAS  Google Scholar 

  • Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. III. Systemic reactions during the rush protocol in patients suffering from asthma. Journal of Allergy and Clinical Immunology 83: 797–801, 1989a

    PubMed  CAS  Google Scholar 

  • Bousquet JA, Hejjaoui A, Michel FB. Specific immunotherapy in asthma. Journal of Allergy and Clinical Immunology 86: 292–306, 1990a

    PubMed  CAS  Google Scholar 

  • Bousquet J, Hejjaoui A, Skassa-Brociek W, Guérin B, Maasch H, et al. Double-blind placebo controlled immunotherapy with mixed grass pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass pollen. Journal of Allergy and Clinical Immunology 80: 591–598, 1987b

    PubMed  CAS  Google Scholar 

  • Bousquet J, Hejjaoui A, Soussana M, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. Journal of Allergy and Clinical Immunology 85: 490–497, 1990b

    PubMed  CAS  Google Scholar 

  • Bousquet J, Maasch H, Hejjaoui A, Skassa-Brociek W, Wahl R. Double-blind placebo controlled immunotherapy with mixed grass pollen allergoids. III. Comparison with an unfractionated allergoid, a fractionated allergoid and a standardized orchard grass pollen extract in rhinitis, conjunctivitis and asthma. Journal of Allergy and Clinical Immunology 84: 546–556, 1989b

    PubMed  CAS  Google Scholar 

  • Bousquet J, Ménardo JL, Velasquez G, Michel FB. Systemic reactions during maintenance immunotherapy with honey bee venom. Annals of Allergy 61: 63–68, 1988

    PubMed  CAS  Google Scholar 

  • Bousquet J, Michel FB. Immunotherapy. In Mygind & Naclerio (Eds) Allergic and non-allergic rhinitis, pp. 137–148, Munskgaard, Copenhagen, 1992a

    Google Scholar 

  • Bousquet J, Müller UR, Dreborg S, Jarisch R, Mailing HJ. Immunotherapy with Hymenopteran venoms. Position Paper of the European Academy of Allergy. Allergy 42: 401–413, 1987c

    PubMed  CAS  Google Scholar 

  • Bruno G, Wüthrich B, Ganderton MA, Hylebrandt N, Costello J. A multicenter trial of immunotherapy with alginate-conjugated grass pollen extract. Annals of Allergy 56: 384–391, 1986

    PubMed  CAS  Google Scholar 

  • Bucur J, Dreborg S, Einarsson R, Ljungstedt-Påhlman I, Nilsson JE, et al. Immunotherapy with dog and cat allergen preparations in dog-sensitive and cat-sensitive asthmatics. Annals of Allergy 62: 355–359, 1989

    PubMed  CAS  Google Scholar 

  • Busse WW, Storms WW, Flaherty DK, Crandall M, Reed CE. Alternaria IgG precipitins and adverse reactions. Journal of Allergy and Clinical Immunology 57: 367–372, 1976

    PubMed  CAS  Google Scholar 

  • Cockroft DW, Cuff MT, Tarlo SM, Dolovich J, Hargreave FE. Allergen injection therapy with glutaraldehyde-modified-ragweed pollen-tyrosine adsorbate: a double-blind trial. Journal of Allergy and Clinical Immunology 60: 56–62, 1977

    Google Scholar 

  • Committee on Safety of Medicines. Desensitizing vaccines. British Medical Journal 293: 948, 1986

    Google Scholar 

  • Corrado OJ, Pastorello E, Ollier S, Cresswell L, Zanussi C, et al. A double-blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac®) in patients with perennial rhinitis. Allergy 44: 108–115, 1989

    PubMed  CAS  Google Scholar 

  • Ds’Souza ME, Pepys J, Wells ID, Tai E, Palmer F, et al. Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects. Clinical Allergy 3: 177–193, 1973

    Google Scholar 

  • Dreborg S, Agrell B, Foucard T, Foucard T, Kjellman NI, et al. A double-blind, multicenter immunotherapy trial in children using a purified and standardized Cladosporium herbarum preparation. Allergy 41: 131–140, 1986

    PubMed  CAS  Google Scholar 

  • Dreborg S, Akerblom EB. Immunotherapy with monomethoxypolyethylene glycol modified allergens. Critical Reviews in Therapeutic Drug Carrier Systems 6: 315–365, 1990

    PubMed  CAS  Google Scholar 

  • Dreborg S, Mosbech H, Weeke B. Immunotherapy (hyposensitization) and bronchial asthma. In Kay (Ed.) Clinical immunology and allergy, Vol. 2, pp. 245–258, Ballière Tindall, London, 1988

    Google Scholar 

  • Ewan PW, Alexander MM, Snape C, Ind PW, Agrell B, et al. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clinical Allergy 18: 501–508, 1988

    PubMed  CAS  Google Scholar 

  • Georgitis JW, Reisman RE, Clayton WF, Mueller UR, Wypych JI, et al. Local intranasal immunotherapy for grass-allergic rhinitis. Journal of Allergy and Clinical Immunology 71: 71–76, 1983

    PubMed  CAS  Google Scholar 

  • Gilman SA, Cummins LH, Kozak PR, Hoffman DR. Venom immunotherapy: comparison of ‘rush’ vs. ‘conventional’ schedules. Annals of Allergy 45: 351–357, 1980

    Google Scholar 

  • Golden DBK, Valentine MD, Kagey-Sobotka A, Lichtenstein LM. Regimens of hymenopteran venom immunotherapy. Annals of Internal Medicine 92: 620–624, 1980

    PubMed  CAS  Google Scholar 

  • Goodman DH, Harris J. Allpyral®: an appraisal. Annals of Allergy 35: 17–25, 1975

    PubMed  CAS  Google Scholar 

  • Grammer LC, Shaughnessy MA, Finkle SM, Shaugnessy JJ, Patterson R. A double-blind placebo-controlled trial of polymerized whole grass administered in an accelerated dosage schedule for immunotherapy of grass pollinosis. Journal of Allergy and Clinical Immunology 78: 1180–1184, 1986a

    PubMed  CAS  Google Scholar 

  • Grammer LC, Shaughnessy MA, Finkle SM, Shaughnessy JJ, Patterson R. Safety and immunogenicity of immunotherapy with polymerized tree, grass, and ragweed in patients with multiple inhalant sensitivities. Journal of Allergy and Clinical Immunology 77: 53–58, 1986b

    PubMed  CAS  Google Scholar 

  • Grammer LC, Shaughnessy MA, Suszko IM, Shaugnessy JJ, Patterson R. A double-blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy. Journal of Allergy and Clinical Immunology 72: 448–453, 1983

    PubMed  CAS  Google Scholar 

  • Grammer LC, Zeiss CR, Suszko IM, Shaughnessy MA, Patterson R. A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy. Journal of Allergy and Clinical Immunology 69: 494–499, 1982

    PubMed  CAS  Google Scholar 

  • Grant AJ. Traitement de ls’allergie aux piqûres de Polistes. Revue Francaise ds’Allergologie et ds’Immunologie Clinique 23: 69–74, 1983

    Google Scholar 

  • Greenberg MA, Kaufman CR, Gonzalez GE, Rosenblatt CD, Smith LJ, et al. Late and immediate systemic-allergic reactions to inhalant allergen immunotherapy. Journal of Allergy and Clinical Immunology 77: 865–870, 1986

    PubMed  CAS  Google Scholar 

  • Greenberg MA, Kaufman CR, Gonzalez GE, Trusewych ZP, Rosenblatt CD, et al. Late systemic-allergic reactions to inhalant allergen immunotherapy. Journal of Allergy and Clinical Immunology 82: 287–290, 1988

    PubMed  CAS  Google Scholar 

  • Haugaard L, Dahl R. Immunotherapy in patients allergic to cat and dog dander. I. Clinical results. Allergy 47: 249–254, 1992

    PubMed  CAS  Google Scholar 

  • Hedlin G, Graff-Lonnevig V, Heilborn H, Lilja G, Norrlind K, et al. Immunotherapy with cat- and dog-dander extracts. II. in vivo and in vitro effects observed in 1-year double-blind placebo study. Journal of Allergy and Clinical Immunology 77: 488–496, 1986

    PubMed  CAS  Google Scholar 

  • Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immuno-therapy schedule. Journal of Allergy and Clinical Immunology 85: 473–479, 1990

    PubMed  CAS  Google Scholar 

  • Hejjaoui J, Ferrando R, Dhivert H, Michel FB, Bousquet J. Systemic reactions occurring during immunotherapy with standardized pollen extracts. Journal of Allergy and Clinical Immunology 89: 925–933, 1992

    PubMed  CAS  Google Scholar 

  • Hepner MJ, Ownby DR, Anderson JA, Rowe MS, Sears-Ewald D, et al. Risk of systemic reactions in patients taking β-blocker drugs receiving allergen immunotherapy injections. Journal of Allergy and Clinical Immunology 86: 407–411, 1990

    PubMed  CAS  Google Scholar 

  • Horst M, Hejjaoui A, Horst V, Michel FB, Bousquet J. Double-blind placebo-controlled rush immunotherapy with a standardized Alternaria extract. Journal of Allergy and Clinical Immunology 85: 460–472, 1990

    PubMed  CAS  Google Scholar 

  • Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amoud FJ, et al. A controlled trial of immunotherapy in insect hypersensitivity. New England Journal of Medicine 299: 157–161, 1978

    PubMed  CAS  Google Scholar 

  • Ilioupoulos O, Proud D, Adkinson NF, Creticos PS, Norman PS, et al. Effects of immunotherapy on the early, late and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. Journal of Allergy and Clinical Immunology 87: 666–855, 1991

    Google Scholar 

  • International Consensus Report on Diagnosis and Management of Asthma. NIH Publication No. 92-3091, US Department of Health and Social Services, Bethesda, 1992

    Google Scholar 

  • Jarisch R, Götz M, Aberer W, Sidl R, Stabel A, et al. Reduction of side effects of specific immunotherapy by premedication with antihistaminics and reduction of maximal dosage to 50.000 SQ-U/ml. Arbeiten aus dem Paul-Ehrlich-Institut für Sera und Imfsoffe, Band 82, pp. 162–175, Gustav Fischer Verlag, Stuttgart, 1988

    Google Scholar 

  • Juniper EF, Kline PA, Ramsdale EH, Hargreave FE. Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis. Journal of Allergy and Clinical Immunology 85: 606–611, 1990

    PubMed  CAS  Google Scholar 

  • Juniper EF, Os’Connor J, Roberts RS, Evans S, Hargreave FE, et al. Polyethylene glycol-modified ragweed extract: comparison of two treatment regimens. Journal of Allergy and Clinical Immunology 78: 851–856, 1986

    PubMed  CAS  Google Scholar 

  • Kaad PH, Østergaard PA. The hazard of mould hyposensitization in children with asthma. Clinical Allergy 12: 317–320, 1982

    PubMed  CAS  Google Scholar 

  • Kaplan AP, Anderson JA, Valentine MD, Lockey RF, Pierson WE, et al. β-Adrenergic blockers, immunotherapy and skin testing. Journal of Allergy and Clinical Immunology 84: 129–310, 1989

    PubMed  CAS  Google Scholar 

  • Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing. Journal of Allergy and Clinical Immunology 79: 660–677, 1987

    PubMed  CAS  Google Scholar 

  • Lockey RF, Turkeltaub PC, Olive ES, Hubbard JM, Baird-Warren IA, et al. The hymenopteran venom study III: safety of venom immunotherapy. Journal of Allergy and Clinical Immunology 86: 775–780, 1990

    PubMed  CAS  Google Scholar 

  • Machiels JJ, Buche M, Somville MA, Jacquemin MG, Saint-Remy JM. Complexes of grass pollen allergens and specific antibodies reduce allergic symptoms and inhibit the seasonal increase of IgE antibody. Clinical and Experimental Allergy 20: 653–660, 1990a

    PubMed  CAS  Google Scholar 

  • Machiels JJ, Somville MA, Jacquemin MG, Saint-Remy JMR. Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergy 46: 335–348, 1991

    PubMed  CAS  Google Scholar 

  • Machiels JJ, Somville MA, Lebrun PM, Lebecque SJ, Jaquemin MG, et al. Allergic bronchial asthma due to Dermatophagoides pteronyssinus can be efficiently treated by inoculation of allergenantibody complexes. Journal of Clinical Investigation 85: 1024–1035, 1990b

    PubMed  CAS  Google Scholar 

  • Mailing H-J, Alvarez E, Basomba A, Bousquet J, Caillot D, et al. Specific immunotherapy. Position Paper of the European Academy of Allergy and Clinical Immunology. Allergy 43(Suppl. 6): 1–33, 1988

    Google Scholar 

  • Mailing HJ, Weeke B. Specific immunotherapy. Second Position Paper of the European Academy of Allergy and Clinical Immunology. Allergy 48(Suppl. 14): 9–35, 1993

    Google Scholar 

  • Mailing H-J, Dreborg S, Weeke B. Diagnosis and immunotherapy of mould allergy V: clinical efficacy and side effects of immunotherapy with Cladosporium herbarum. Allergy 41: 507–516, 1986

    Google Scholar 

  • Marques RA, Avila R. Results of a clinical trial with Dermatophagoides pteronyssinus tyrosine adsorbed vaccine. Allergologia et Immunopatholologia 6: 231–235, 1978

    Google Scholar 

  • Meriney DK, Kothari H, Chinoy P, Grieco MH. The clinical and immunologic efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever. Annals of Allergy 56: 34–38, 1986

    PubMed  CAS  Google Scholar 

  • Miller ACML. A trial of hyposensitization in 1974/5 in the treatment of hay fever using a glutaraldehyde-pollen-tyrosine adsorbate. Clinical Allergy 6: 557–561, 1979

    Google Scholar 

  • Møller C, Dreborg S, Lanner A, Bjorksten B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study. Allergy 41: 271–279, 1986

    PubMed  Google Scholar 

  • Mosbech H, Dirksen A, Dreborg S, Frølund L, Heinig JH, et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract. IV: occurrence and prediction of side effects. Allergy 45: 142–150, 1990

    PubMed  CAS  Google Scholar 

  • Müller U, Hlebling A, Berchtold E. Immunotherapy with honey bee venom is different regarding efficacy and safety. Journal of Allergy and Clinical Immunology 89: 529–535, 1992

    PubMed  Google Scholar 

  • Müller U, Horat W, Wuthrich B, Conroy M, Reisman RE. Anaphylaxie after hymenopteran stings in three patients with urticaria pigmentosa. Journal of Allergy and Clinical Immunology 72: 685–691, 1983

    PubMed  Google Scholar 

  • Müller U, Lanner A, Schmidt P, Bischof M, Dreborg S, et al. A double-blind study on immunotherapy with chemically modified honey bee venom in PEG-coupled versus crude honey bee venom. International Archives of Allergy and Applied Immunology 77: 201–203, 1985

    PubMed  Google Scholar 

  • Müller U, Morris T, Bischof M, Friedli H, Skvaril F. Combined active and passive immunotherapy in honey bee sting allergy. Journal of Allergy and Clinical Immunology 78: 115–122, 1986

    PubMed  Google Scholar 

  • Müller U, Mosbech H, Blaauw P, Dreborg S, Mailing HJ, et al. Emergency treatment of allergic reactions to hymenopteran stings. Clinical and Experimental Allergy 21: 281–289, 1991

    PubMed  Google Scholar 

  • Nataf P, Guinepain MR, Herman D. Rush venom immunotherapy. A 3-day programme. Clinical Allergy 14: 269–26, 1984

    PubMed  CAS  Google Scholar 

  • Nelson BL, Dupont LA, Reid MJ. Prospective survey of local and systemic reactions to immunotherapy with pollen extracts. Annals of Allergy 56: 331–334, 1986

    PubMed  CAS  Google Scholar 

  • Noon L, Cantab BC. Prophylactic inoculation against hay fever. Lancet 1: 1572–1573, 1911

    Google Scholar 

  • Norman PS. Fatal misadventures. Journal of Allergy and Clinical Immunology 79: 572–573, 1987

    PubMed  CAS  Google Scholar 

  • Norman PS, Kunkel G, Weeke B. Immunotherapy. In Mygind & Weeke (Eds) Allergic and vasomotor rhinitis: clinical aspects, pp. 132–139, Munksgaard, Copenhagen, 1986

    Google Scholar 

  • Norman PS, Lichtenstein LM, Kagey-Sobotka A, Marsh DG. Controlled evaluation of allergoids in the immunotherapy of ragweed hay fever. Journal of Allergy and Clinical Immunology 70: 248–260, 1982

    PubMed  CAS  Google Scholar 

  • Norman PS, Winkelwerder WL, Lichtenstein L. Immunotherapy of hay fever with ragweed antigen E: comparisons with whole extracts and placebo. Journal of Allergy 42: 93–108, 1968

    PubMed  CAS  Google Scholar 

  • Ohman JL, Findlay SR, Leitermann KM. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. Journal of Allergy and Clinical Immunology 74: 230–239, 1984

    PubMed  Google Scholar 

  • Østerballe O. Immunotherapy in hay fever with two major allergens 19,25 and partially purified extracts of timothy pollen. A controlled double-blind study. In vivo variables, season. I. Allergy 35: 473–489, 1980

    PubMed  Google Scholar 

  • Pastorello EA, Pravettoni V, Incorvaia C, Mambretti M, Franck E, et al. Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass induced hay fever. Allergy 47: 281–290, 1992

    PubMed  CAS  Google Scholar 

  • Pauli G, Bessot JC, Bigot H, Delaume G, Hordle DA, et al. Clinical and immunological evaluation of tyrosine adsorbed Dermatophagoides pteronyssinus extract: a double-blind placebocontrolled trial. Journal of Allergy and Clinical Immunology 74: 524–535, 1984

    PubMed  CAS  Google Scholar 

  • Pegelow K-O, Belin L, Broman P, Heilborn H, Sundin B, et al. Immunotherapy with alginate-conjugated and alum-precipitated grass pollen extracts in patients with allergic rhino-conjunctivitis. Allergy 39: 275–290, 1984

    PubMed  CAS  Google Scholar 

  • Philip Jouet F, Anfosso-Capra F, Reynaud-Gaubert M, Arnaud A. Efficacité et tolérance ds’un protocole ds’accoutumance au venin ds’hyménopteres en 3 heures 30. Revue Francaise ds’Allergologie et ds’Immunologie Clinique 30: 221–224, 1990

    Google Scholar 

  • Position Paper. The waiting period after allergen skin testing and immunotherapy. Journal of Allergy and Clinical Immunology 84: 526, 1989

    Google Scholar 

  • Price LA, Safko M. Bee venom allergy in a patient with urticaria pigmentosa. Journal of Allergy and Clinical Immunology 79: 407–409, 1987

    PubMed  CAS  Google Scholar 

  • Ramirez DA, Londono SA, Evans III R. Adverse reactions to venom immunotherapy. Annals of Allergy 47: 435–439, 1981

    PubMed  CAS  Google Scholar 

  • Rohatgi N, Dunn K, Chai H. Cat- or dog-induced immediate and late asthmatic responses before and after immunotherapy. Journal of Allergy and Clinical Immunology 82: 389–397, 1988

    PubMed  CAS  Google Scholar 

  • Rzany B, Przybilla B, Jarisch R, Aberer W, Dietschi R, et al. Clinical characteristics of patients with repeated systemic reactions during specific immunotherapy with hymenopteran venoms. Allergy 46: 251–254, 1991

    PubMed  CAS  Google Scholar 

  • Stewart GE, Lockey RF. Systemic reactions from allergen immunotherapy. Journal of Allergy and Clinical Immunology 90: 567–579, 1992

    PubMed  Google Scholar 

  • Tarhini H, Knani J, Michel FB, Bousquet J. Safety of venom immunotherapy administered by a cluster schedule. Journal of Allergy and Clinical Immunology 89: 1198–1199, 1992

    PubMed  CAS  Google Scholar 

  • Thompson RA, Bousquet J, Cohen S, Frei PC, Jager L, et al. Allergen specific immunotherapy. Report of a WHO-IUIS working group, Lancet 1: 259–261, 1989

    Google Scholar 

  • Thurnheer U, Müller U, Stoller R, Lanner A, Hoigné R. Venom immunotherapy in hymenopteran sting allergy. Observations during long term treatment. Allergy 38: 465–475, 1983

    PubMed  CAS  Google Scholar 

  • Turkeltaub PC, Campbell G, Mosimann JE. Comparative safety and efficacy of short ragweed extracts differing in potency and composition in the treatment of fall hay fever. Use of allergenically bioequivalent doses by parallel line bioassay to evaluate comparative safety and efficacy. Allergy 45: 528–546, 1990

    PubMed  CAS  Google Scholar 

  • Urbanek R. Rush hyposensitization of children allergic to hymenopteran venom. In Johansson (Ed.) Diagnosis and treatment of IgE-mediated diseases, pp. 289–296, Skandia International Symposium, Stockholm, 1982

    Google Scholar 

  • Valovirta E, Viander M, Koivikko A, Vanto T, Ingemann L. Immunotherapy in allergy to dog. Immunologic and clinical findings of a double blind study. Annals of Allergy 57: 173–179, 1986

    PubMed  CAS  Google Scholar 

  • Van Arsdel PP, Sherman WB. The risk of inducing constitutional reactions in allergic patients. Journal of Allergy 28: 251–263, 1957

    Google Scholar 

  • Van der Zwan JC, Flinterman J, Jankowski IG, Kerchaert JAM. Hyposensitization to wasp venom in six hours. British Medical Journal 287: 1329–1331, 1983

    PubMed  Google Scholar 

  • Van Metre Jr TE, Adkinson Jr NF. Immunotherapy for aeroallergen disease. In Middleton et al. (Eds) Allergy, principles and practice, pp. 1327–1344, 3rd ed., Mosby Co., St Louis, 1989

    Google Scholar 

  • Van Metre TE, Adkinson Jr NF, Amodio FJ, Kagey-Sobotka A, Lichtenstein LM, et al. A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever. Journal of Allergy and Clinical Immunology 66: 500–513, 1981

    Google Scholar 

  • Van Metre TE, Adkinson NF, Lichtenstein LM, Mardiney MR, Norman PS, et al. A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever. Journal of Allergy and Clinical Immunology 65: 288–297, 1980

    PubMed  Google Scholar 

  • Van Metre TE, Marsh DG, Adkinson Jr NF, Kagey-Sobotka A, Khattignavong A, et al. Immunotherapy for cat asthma. Journal of Allergy and Clinical Immunology 82: 1055–1068, 1988

    PubMed  Google Scholar 

  • Varney VA, Gaga M, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. British Medical Journal 302: 265–269, 1991

    PubMed  CAS  Google Scholar 

  • Verstraeten JM, Wheeler AW. A comparative study of an aqueous grass pollen extract and glutaraldehyde-treated grass pollen-tyrosine adsorbate in the treatment of pollenosis. Clinical Allergy 8: 435–443, 1978

    PubMed  CAS  Google Scholar 

  • Vervloet D, Khairallal E, Arnaud A, Charpin J. A prospective national study of the safety of immunotherapy. Clinical Allergy 10: 59–64, 1980

    PubMed  CAS  Google Scholar 

  • Warner JO, Price JF, Soothill JF, Hey EN. Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma. Lancet 2: 912–916, 1978

    PubMed  CAS  Google Scholar 

  • Wyss M, Scheitlin T, Stadler BN, Wuthrich B. Immunotherapy with aluminium hydroxide adsorbed insect venom extracts (Alutard SQ). Immunologie and clinical results of a prospective study over 3 years. Allergy 48: 81–86, 1993

    PubMed  CAS  Google Scholar 

  • Yunginger JW, Pauli BR, Jones RP, Santrach PJ. Rush immunotherapy programme for honey bee sting sensitivity. Journal of Allergy and Clinical Immunology 163: 340–347, 1979

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinique des Maladies Respiratoires, Hôpital Arnaud de Villeneuve, Centre Hospitalier Universitaire, 34059, Montpellier Cedex, France

    Jean Bousquet MD, PhD & François-B. Michel

Authors
  1. Jean Bousquet MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. François-B. Michel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bousquet, J., Michel, FB. Safety Considerations in Assessing the Role of Immunotherapy in Allergic Disorders. Drug-Safety 10, 5–17 (1994). https://doi.org/10.2165/00002018-199410010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199410010-00002

Keywords

Search

Navigation